S. Suciu

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group.

A. Eggermont, C. Punt, P. Patel, 2006, European journal of cancer.

Modulation of multidrug-resistant multiple myeloma by cyclosporin

P. Sonneveld, R. Zittoun, S. Suciu, 1992, The Lancet.

High tPA-expression in primary melanoma of the limb correlates with good prognosis

A. Eggermont, U. Kleeberg, H. Straatman, 2000, British Journal of Cancer.